PUBLISHED DATE : Jul 2023 | Pages : 370
Fill out your details & get your free sample
The Vital Signs Monitoring Devices Market Size, Share, & Trends Analysis Report By
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023–2028
370 Pages
159 Tables
158 Charts
5 Regions
19 Countries
62 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2028) | USD 33.36 Billion |
| Market Size (2022) | USD 20.60 Billion |
| CAGR (2022-2028) | 8.36% |
| Base Year | 2022 |
| Forecast Year | 2023-2028 |
| Market Segments | Product Type, Patient Group, Application, End-users, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | A&D Company, Contec Medical Systems, GE Healthcare, Baxter, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems |
The global vital signs monitoring devices market was valued at USD 20.60 billion in 2022 and is expected to reach USD 33.36 billion by 2028, growing at a CAGR of 8.36%. In recent years, vital sign monitoring has expanded and extended beyond the limits of medical practices and most areas of everyday life. Previously, vital sign monitoring occurred in clinics, hospitals, and other healthcare systems under the appropriate medical supervision. But, in recent years, technological advances such as microelectronics have resulted in cost reductions in vital monitoring systems. These technologies are highly accessible and common in telemedicine, fitness, sports, wellness, and the workplace. Despite those expansions and given the health-associated nature of these applications, quality standards remain high. The growing requirement for continuous healthcare monitoring and the shortage of trained medical professionals offers a significant opportunity for advancement & innovations in the vital signs monitoring devices market. The microelectronic technologies & sensor domains have a vibrant innovation ecosystem focusing on multi-parametric sensing, improving sensitivity, & wireless sensing.
Vital sign monitoring involves measuring physiological parameters that can indicate health. Heart rate is one of the most common vital signs detected through the electrocardiogram principle. The recent advances in vital sign monitoring devices with Deep Learning (DL) and Machine Learning (ML) have strengthened the power of imaging techniques to help remotely perform many tasks which were previously required the physical presence of medical professionals. Also, the upcoming wearable vital sign monitoring devices positively influence the vital signs monitoring devices market growth.
Technology Development in Vital Sign Monitoring Devices
With the advances in technologies in the vital signs monitoring devices market, advanced vital sign devices become more common in various healthcare filed and across daily lives. Whether it is used for prevention or management, such health-associated solutions call for robust and reliable technology. Internet of Things (IoT) is a major factor that penetrated 50% of healthcare in developed and rapidly developing countries, from patient care management to post-care. Recently, the advancement in vital sign monitoring devices, such as the addition of sensors, software integrations, digital screens, and mobile-based applications, resulted in rapid development.
Growing Shift Towards Remote Patient Monitoring (RPM)
RPM has enabled medical professionals to observe patients virtually along with vital clinical information and make decisions to improve care outcomes. In these procedures, vital sign monitoring devices accurately deliver clinical data to medical professionals. The increasing demand for remote patient monitoring is accelerating the growth of the vital signs monitoring devices market. Further, remote patient monitoring helps improve quality of life by being cost-effective and reducing the chance of hospitalization. In addition, the older population's preferences for home care settings are accelerating the demand for vital sign monitoring devices.
Enhance Adoption with Patient-centric Digital Systems with Wearable Devices & Telemedicine
In healthcare settings, increasing demand for telemedicine/telehealth is expected to drive remote monitoring. In contrast, accurate monitoring and diagnosis system will be most important to collect vital signs and other data points. Where the increasing shifts towards telemedicine platforms to deliver and receive care, vital sign monitoring devices are playing a vital role. As in healthcare management, multi-sensor and wearable technologies emerge, digital devices integration of electronic health records (EHRs) expects to optimize day-to-day operations and offers data for strategic decision making.
Increasing Burden of Chronic Disorders
Globally, healthcare settings are witnessing for increasing burden of chronic disorders. Chronic conditions pose a mental and financial burden. However, the vital signs monitoring devices market has witnessed huge growth and development. The year-on-year increasing patient population with minor to severe chronic conditions drives the significant demand for vital sign monitoring devices because it not only helps to reduce the burden but also offers early indications that reduce the risk of mortality, morbidity, and disability of individuals.
Available Integrated Vital Sign Monitoring Devices Offer More Benefits
In healthcare, vital sign monitoring systems are rapidly becoming more popular and core. It shifted the traditional paradigm and manual clinical data recording to computer-based electronic records and handheld devices as innovative and versatile healthcare monitoring systems. Still, there are a lot of challenges in patient monitoring. Based on that, integrating vital sign monitoring devices offers a lucrative advantage in driving the market growth. Furthermore, the term multiparameter monitors become more favorable over the last decades, which boosts the vital signs monitoring devices market growth. In healthcare settings and other external and internal health delivery systems, a multiparameter monitor is a major medical device for monitoring patients' vital signs. It is mostly used in intensive care units, emergency rooms, and hospitalizations.
INSIGHTS BY PRODUCT
The global vital signs monitoring devices market by product is segmented into standalone and integrated vital sign monitoring devices. The standalone vital sign monitoring devices include the heart rate/cardiac monitor, pulse oximeter, blood pressure monitor, and body temperature monitor. Standalone vital sign monitors are easy to transfer from one location to another. They are typically lightweight and compact, making it easy to keep looks on a given patient’s vital signs wherever they are. In 2022, the standalone vital sign monitors segment accounted for a higher industry share. A standalone system is envisioned that monitors all patients' vital signs and automatically alerts the required emergency response services upon recognizing a crisis condition.
INSIGHTS BY PATIENT GROUP
The global vital signs monitoring devices market by the patient group is segmented into geriatric, pediatric, and adult patient groups. With the growing burden of chronic diseases among geriatric populations, the demand for vital sign monitors is generally high. The geriatric segment dominated the market by over 53% share in 2022. The high hospitalization visits and the huge preference for outpatient and homecare settings are accelerating the demand for vital sign monitoring devices from the aging patient population.
INSIGHTS BY APPLICATION
The chronic care application segment dominated the global vital signs monitoring devices market. Chronic conditions are long-term impacting conditions with persistent effects. Their economic and social consequences can impact on people's quality of life. These conditions are becoming increasingly common and one of the priority areas of healthcare settings. Chronic diseases affect over 60% of the world's population and consume over 85% of healthcare expenditures. It indicates that huge opportunities are available for vendors with the increasing chronic disease burden worldwide.
INSIGHTS BY END-USER
The global vital signs monitoring devices market by end-user is segmented into hospitals, homecare settings & individuals, ambulatory care settings, and others. Hospitals are major healthcare settings worldwide, contributing to the huge demand for vital sign monitors. Hospitals are the primary source of care for every patient group. Millions of hospital visits and admissions are fuelling the demand for vital sign monitors. Also, developing vital sign monitoring devices with the integrated model approach accelerates the market growth.
The North American region dominated the vital signs monitoring devices market share, accounting for over 35% in 2022. The early adoption of medical technologies across the U.S. drives vital sign monitoring devices' huge acceptance and application rate. The awareness about using vital sign monitors among individuals and the huge transformation of healthcare settings with digitalization and advanced technologies are accelerating the demand for standalone vital sign monitors across the US. In addition, the well-known approach for remote patient monitoring boosts the use of wearable vital sign monitors.
In Europe, the shift towards connected health technologies among patients and healthcare settings offers lucrative vital signs monitoring devices market growth opportunities. Currently, digital health technologies hold the potential to bring about huge improvements in the health systems of Europe in terms of care provision and administration. Furthermore, the challenges posed by COVID-19 have created different requirements and a new willingness to adopt connected health technologies.
In APAC, several countries have been focusing on implementing telemedicine platforms recently, shifting people's preference from hospital-based medical services to day-to-day healthcare services at home. The Asia-Pacific Economic Corporation (APEC) is actively helping and promoting the use of telemedicine platforms in the region, which is expected to drive around 50% growth in telemedicine in the upcoming ten years. Japan and Korea have a huge medical information foundation and gradually support telemedicine platforms. Thereby accelerating the demand for remote patient monitoring and supporting the vital signs monitoring devices market.
The vital signs monitoring devices market is highly competitive and has several major players. The fragmented market has various global, local, and regional manufacturers. Owing to continuous technological advancements and product innovations, mid-sized and emerging vendors are increasing their market presence by introducing new products at competitive prices. Also, the market potential drives several players to expand their industry share through acquisitions. Many vendors are adopting strategies to increase their presence in major markets. Larger players also tend to acquire other companies as a whole or specific product portfolio.
A&D Company, Hillrom, Masimo, Medtronic, Koninklijke Philips, GE Healthcare, Contec Medical Systems, NIHON KOHDEN, and Smiths Medical are some of the major vendors in the global vital signs monitoring devices market offering a wide range of both standalone and integrated vital signs monitors worldwide. All these companies have a significant presence in major geographical regions such as North America, APAC, and Europe. However, many local vendors provide products with similar specifications at lower prices, which has resulted in a price war among vendors. The major vendors continuously compete for the leading position in the market, with occasional competition coming from other local vendors.
Frequently Asked Questions
How big is the global vital signs monitoring devices market?
The global vital signs monitoring devices market size was valued at USD 20.60 billion in 2022 and is expected to reach USD 33.36 billion by 2028.
What is the growth rate of the vital signs monitoring devices market?
The global vital signs monitoring devices market is growing at a CAGR of 8.36% from 2022-2028.
What are the rising trends in the vital signs monitoring devices industry?
The rising trends in the vital signs monitoring devices industry are technology development in vital sign monitoring devices, a growing shift towards remote patient monitoring technology, and enhanced adoption of patient-centric digital systems with wearable devices & telemedicine.
Which region holds the most significant global vital signs monitoring devices market share?
North America dominated the global vital signs monitoring devices market share in 2022, accounting for over 35%.
Who are the key players in the global vital signs monitoring devices market?
A&D Company, Contec Medical Systems, GE Healthcare, Baxter, ICU Medical, Koninklijke Philips, Masimo, Medtronic, NIHON KOHDEN, Nonin, OMRON, and OSI Systems are the key players in the vital global vital signs monitoring devices market.
The global vital signs monitoring devices market is expected to grow at a CAGR of approximately 8.36% from 2022 to 2028.
The following factors are likely to contribute to the growth of the vital signs monitoring devices market during the forecast period:
Base Year: 2022
Forecast Year: 2023-2028
The report considers the present scenario of the global vital signs monitoring devices market and its market dynamics for 2023−2028. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
Key Company Profiles
Other Prominent Vendors
Segmentation by Product Type
Segmentation By Patient Group
Segmentation by Application
Segmentation By End-users
Segmentation By Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY PATIENT GROUP
4.3.3 MARKET SEGMENTATION BY APPLICATION
4.3.4 MARKET SEGMENTATION BY END USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
6.1.1 MARKET SEGMENTATION
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 TECHNOLOGICAL ADVANCES IN VITAL SIGNS MONITORING DEVICES
9.2 SHIFT TOWARD REMOTE PATIENT MONITORING TECHNOLOGIES
9.3 HIGH ADOPTION OF PATIENT-CENTRIC DIGITAL SYSTEMS & TELEMEDICINE
10 MARKET GROWTH ENABLERS
10.1 RISE IN BURDEN OF CHRONIC DISORDERS
10.2 AVAILABILITY OF INTEGRATED VITAL SIGNS MONITORING DEVICES
10.3 PARADIGM SHIFT TOWARD OUTPATIENT CARE
10.4 EXPANSION OF PATIENT POPULATIONS & SHORTAGE OF HEALTHCARE WORKERS
11 MARKET RESTRAINTS
11.1 CHALLENGES ASSOCIATED WITH REMOTELY MONITORING PATIENTS THROUGH VITAL SIGN MONITORS
11.2 FALSE ALARMS RELATED TO VITAL SIGN MONITORING DEVICES
11.3 CYBERSECURITY & RELATED LIMITATIONS OF VITAL SIGNS MONITORING DEVICES
11.4 PERCEPTIONS OF INADEQUATE ACCURACY & RELIABILITY OF WIRELESS VITAL SIGNS MONITORING DEVICES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 PRODUCT INSIGHTS: MARKET ANALYSIS
12.1.2 STANDALONE VITAL SIGN MONITORING DEVICES TYPES INSIGHTS: MARKET ANALYSIS
12.1.3 PATIENT GROUP INSIGHTS: MARKET ANALYSIS
12.1.4 APPLICATION INSIGHTS: MARKET ANALYSIS
12.1.5 END-USER INSIGHTS: MARKET ANALYSIS
12.1.6 GEOGRAPHY INSIGHTS: MARKET ANALYSIS
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 STANDALONE VITAL SIGN MONITORS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET BY GEOGRAPHY
13.3.3 HEART RATE/ CARDIAC MONITORS: MARKET SIZE & FORECAST
13.3.4 PULSE OXIMETERS: MARKET SIZE & FORECAST
13.3.5 BLOOD PRESSURE MONITORS: MARKET SIZE & FORECAST
13.3.6 BODY TEMPERATURE MONITORS: MARKET SIZE & FORECAST
13.4 INTEGRATED VITAL SIGN MONITORS
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 PATIENT GROUP
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 GERIATRIC
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 PEDIATRIC
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 ADULTS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
15 APPLICATION
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 CHRONIC CARE
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 ACUTE CARE
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 END USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HOSPITALS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 OUTPATIENT CARE SETTINGS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 HOMECARE SETTINGS & INDIVIDUALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 PRODUCT
18.3.1 MARKET SIZE & FORECAST
18.4 STANDALONE VITAL SIGN MONITORS
18.4.1 MARKET SIZE & FORECAST
18.5 PATIENT GROUP
18.5.1 MARKET SIZE & FORECAST
18.6 APPLICATION
18.6.1 MARKET SIZE & FORECAST
18.7 END USER
18.7.1 MARKET SIZE & FORECAST
18.8 KEY COUNTRIES
18.8.1 US: MARKET SIZE & FORECAST
18.8.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 PRODUCT
19.3.1 MARKET SIZE & FORECAST
19.4 STANDALONE VITAL SIGN MONITORS
19.4.1 MARKET SIZE & FORECAST
19.5 PATIENT GROUP
19.5.1 MARKET SIZE & FORECAST
19.6 APPLICATION
19.6.1 MARKET SIZE & FORECAST
19.7 END USER
19.7.1 MARKET SIZE & FORECAST
19.8 KEY COUNTRIES
19.8.1 GERMANY: MARKET SIZE & FORECAST
19.8.2 FRANCE: : MARKET SIZE & FORECAST
19.8.3 UK: MARKET SIZE & FORECAST
19.8.4 ITALY: MARKET SIZE & FORECAST
19.8.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 PRODUCT
20.3.1 MARKET SIZE & FORECAST
20.4 STANDALONE VITAL SIGN MONITORS
20.4.1 MARKET SIZE & FORECAST
20.5 PATIENT GROUP
20.5.1 MARKET SIZE & FORECAST
20.6 APPLICATION
20.6.1 MARKET SIZE & FORECAST
20.7 END USER
20.7.1 MARKET SIZE & FORECAST
20.8 KEY COUNTRIES
20.8.1 CHINA: MARKET SIZE & FORECAST
20.8.2 JAPAN: MARKET SIZE & FORECAST
20.8.3 INDIA: MARKET SIZE & FORECAST
20.8.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.8.5 AUSTRALIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 PRODUCT
21.3.1 MARKET SIZE & FORECAST
21.4 STANDALONE VITAL SIGN MONITORS
21.4.1 MARKET SIZE & FORECAST
21.5 PATIENT GROUP
21.5.1 MARKET SIZE & FORECAST
21.6 APPLICATION
21.6.1 MARKET SIZE & FORECAST
21.7 END USER
21.7.1 MARKET SIZE & FORECAST
21.8 KEY COUNTRIES
21.8.1 BRAZIL: MARKET SIZE & FORECAST
21.8.2 MEXICO: MARKET SIZE & FORECAST
21.8.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.3 PRODUCT
22.3.1 MARKET SIZE & FORECAST
22.4 STANDALONE VITAL SIGN MONITORS
22.4.1 MARKET SIZE & FORECAST
22.5 PATIENT GROUP
22.5.1 MARKET SIZE & FORECAST
22.6 APPLICATION
22.6.1 MARKET SIZE & FORECAST
22.7 END USER
22.7.1 MARKET SIZE & FORECAST
22.8 KEY COUNTRIES
22.8.1 TURKEY: MARKET SIZE & FORECAST
22.8.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.8.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22.8.4 UAE: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.1.1 MAJOR MERGERS & ACQUISITIONS
23.1.2 PRODUCTS LAUNCHES
24 KEY COMPANY PROFILES
24.1 A&D COMPANY
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.1.3 KEY STRATEGIES
24.1.4 KEY STRENGTHS
24.1.5 KEY OPPORTUNITIES
24.2 CONTEC MEDICAL SYSTEMS
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.2.3 KEY STRATEGIES
24.2.4 KEY STRENGTHS
24.2.5 KEY OPPORTUNITIES
24.3 GE HEALTHCARE
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.3.3 KEY STRATEGIES
24.3.4 KEY STRENGTHS
24.3.5 KEY OPPORTUNITIES
24.4 BAXTER
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.4.3 KEY STRATEGIES
24.4.4 KEY STRENGTHS
24.4.5 KEY OPPORTUNITIES
24.5 ICU MEDICAL
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.5.3 KEY STRATEGIES
24.5.4 KEY STRENGTHS
24.5.5 KEY OPPORTUNITIES
24.6 KONINKLIJKE PHILIPS
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.6.3 KEY STRATEGIES
24.6.4 KEY STRENGTHS
24.6.5 KEY OPPORTUNITIES
24.7 MASIMO
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.7.3 KEY STRATEGIES
24.7.4 KEY STRENGTHS
24.7.5 KEY OPPORTUNITIES
24.8 MEDTRONIC
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.8.3 KEY STRATEGIES
24.8.4 KEY STRENGTHS
24.8.5 KEY OPPORTUNITIES
24.9 NIHON KOHDEN
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.9.3 KEY STRATEGIES
24.9.4 KEY STRENGTHS
24.9.5 KEY OPPORTUNITIES
24.10 NONIN
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.10.3 KEY STRATEGIES
24.10.4 KEY STRENGTHS
24.10.5 KEY OPPORTUNITIES
24.11 OMRON
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.11.3 KEY STRATEGIES
24.11.4 KEY STRENGTHS
24.11.5 KEY OPPORTUNITIES
24.12 OSI SYSTEMS
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.12.3 KEY STRATEGIES
24.12.4 KEY STRENGTHS
24.12.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 100PLUS
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 ARJO (HUNTLEIGH HEALTHCARE LIMITED)
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 AMERICAN DIAGNOSTICS
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 ADVANCED INSTRUMENTATIONS
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 BIOFOURMIS
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 BITTIUM
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 BIOINTELLISENSE
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 CARDINAL HEALTH
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 COMPASS HEALTH BRANDS
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 DRÄGERWERK AG & CO.
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 ESSENCE
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 EDAN INSTRUMENTS
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 FUKUDA DENSHI
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 HALMA
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
25.15 INFINIUM MEDICAL
25.15.1 BUSINESS OVERVIEW
25.15.2 PRODUCT OFFERINGS
25.16 MENNEN MEDICAL
25.16.1 BUSINESS OVERVIEW
25.16.2 PRODUCT OFFERINGS
25.17 MICROLIFE
25.17.1 BUSINESS OVERVIEW
25.17.2 PRODUCT OFFERINGS
25.18 NURECA
25.18.1 BUSINESS OVERVIEW
25.18.2 PRODUCT OFFERINGS
25.19 OXITONE
25.19.1 BUSINESS OVERVIEW
25.19.2 PRODUCT OFFERINGS
25.20 QARDIO
25.20.1 BUSINESS OVERVIEW
25.20.2 PRODUCT OFFERINGS
25.21 ROSSMAX INTERNATIONAL
25.21.1 BUSINESS OVERVIEW
25.21.2 PRODUCT OFFERINGS
25.22 SOLARIS MEDICAL TECHNOLOGY
25.22.1 BUSINESS OVERVIEW
25.22.2 PRODUCT OFFERINGS
25.23 SUNSET HEALTHCARE SOLUTIONS
25.23.1 BUSINESS OVERVIEW
25.23.2 PRODUCT OFFERINGS
25.24 TURTLE SHELL TECHNOLOGIES PVT. LTD. (DOZEE)
25.24.1 BUSINESS OVERVIEW
25.24.2 PRODUCT OFFERINGS
25.25 VIATOM TECHNOLOGY
25.25.1 BUSINESS OVERVIEW
25.25.2 PRODUCT OFFERINGS
25.26 VITALCONNECT
25.26.1 BUSINESS OVERVIEW
25.26.2 PRODUCT OFFERINGS
25.27 VIVALNK
25.27.1 BUSINESS OVERVIEW
25.27.2 PRODUCT OFFERINGS
25.28 VYAIRE MEDICAL
25.28.1 BUSINESS OVERVIEW
25.28.2 PRODUCT OFFERINGS
25.29 COSINUSS
25.29.1 BUSINESS OVERVIEW
25.29.2 PRODUCT OFFERINGS
25.30 BETTER LIFE MEDICAL TECHNOLOGY
25.30.1 BUSINESS OVERVIEW
25.30.2 PRODUCT OFFERINGS
25.31 TAIDOC
25.31.1 BUSINESS OVERVIEW
25.31.2 PRODUCT OFFERINGS
25.32 AXCENT MEDICAL
25.32.1 BUSINESS OVERVIEW
25.32.2 PRODUCT OFFERINGS
25.33 GENERAL MEDITECH
25.33.1 BUSINESS OVERVIEW
25.33.2 PRODUCT OFFERINGS
25.34 CLARITY MEDICAL
25.34.1 BUSINESS OVERVIEW
25.34.2 PRODUCT OFFERINGS
25.35 HICKS THERMOMETERS INDIA
25.35.1 BUSINESS OVERVIEW
25.35.2 PRODUCT OFFERINGS
25.36 MEDICAL ECONET
25.36.1 BUSINESS OVERVIEW
25.36.2 PRODUCT OFFERINGS
25.37 MEDITECH
25.37.1 BUSINESS OVERVIEW
25.37.2 PRODUCT OFFERINGS
25.38 SHENZHEN CREATIVE INDUSTRY
25.38.1 BUSINESS OVERVIEW
25.38.2 PRODUCT OFFERINGS
25.39 PROGETTI
25.39.1 BUSINESS OVERVIEW
25.39.2 PRODUCT OFFERINGS
25.40 GENTEMED MEDICAL AND INFROMATION TECHNOLOGY
25.40.1 BUSINESS OVERVIEW
25.40.2 PRODUCT OFFERINGS
25.41 SHENZHEN UNICARE ELECTRONIC
25.41.1 BUSINESS OVERVIEW
25.41.2 PRODUCT OFFERINGS
25.42 OPTO CIRCUITS (INDIA)
25.42.1 BUSINESS OVERVIEW
25.42.2 PRODUCT OFFERINGS
25.43 BEIJING CHOICE ELECTRONIC TECHNOLOGY
25.43.1 BUSINESS OVERVIEW
25.43.2 PRODUCT OFFERINGS
25.44 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS
25.44.1 BUSINESS OVERVIEW
25.44.2 PRODUCT OFFERINGS
25.45 REMOTE DIAGNOSTIC TECHNOLOGIES
25.45.1 BUSINESS OVERVIEW
25.45.2 PRODUCT OFFERINGS
25.46 ZZZSAMTRONIC
25.46.1 BUSINESS OVERVIEW
25.46.2 PRODUCT OFFERINGS
25.47 CHARMCARE
25.47.1 BUSINESS OVERVIEW
25.47.2 PRODUCT OFFERINGS
25.48 AVI HEALTHCARE
25.48.1 BUSINESS OVERVIEW
25.48.2 PRODUCT OFFERINGS
25.49 RECORDERS & MEDICARE SYSTEMS
25.49.1 BUSINESS OVERVIEW
25.49.2 PRODUCT OFFERINGS
25.50 ACARE TECHNOLOGY
25.50.1 BUSINESS OVERVIEW
25.50.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY GEOGRAPHY
27.2 MARKET BY PRODUCT
27.3 MARKET BY STANDALONE VITAL SIGN MONITORS
27.4 MARKET BY PATIENT GROUP
27.5 MARKET BY APPLICATION
27.6 MARKET BY END USER
28 APPENDIX
28.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL VITAL SIGNS MONITORING DEVICES MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 VITAL SIGN MONITORING METHODS
EXHIBIT 4 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET SEGMENTATION
EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN VITAL SIGNS MONITORING DEVICES
EXHIBIT 6 IMPACT OF SHIFT TOWARD REMOTE PATIENT MONITORING TECHNOLOGIES
EXHIBIT 7 STATISTICS ABOUT REMOTE PATIENT MONITORING
EXHIBIT 8 PARAMETERS FOR EFFICACY OF REMOTE PATIENT MONITORING AMONG US PATIENTS (%)
EXHIBIT 9 VOLUME OF HEALTH INSURANCE CLAIMS FOR GENERAL RPM & CONTINUOUS GLUCOSE MONITORING (PRE-PANDEMIC & PANDEMIC PERIOD)
EXHIBIT 10 IMPACT OF HIGH ADOPTION OF PATIENT-CENTRIC DIGITAL SYSTEMS & TELEMEDICINE
EXHIBIT 11 IMPACT OF RISE IN BURDEN OF CHRONIC DISORDERS
EXHIBIT 12 GLOBAL BURDEN OF CHRONIC DISORDERS 2020
EXHIBIT 13 GLOBAL DIABETES PREVALENCE BY GEOGRAPHIES 2020 (MILLION)
EXHIBIT 14 IMPACT OF AVAILABILITY OF INTEGRATED VITAL SIGNS MONITORING DEVICES
EXHIBIT 15 IMPACT OF PARADIGM SHIFT TOWARD OUTPATIENT CARE
EXHIBIT 16 MAJOR ADVANTAGES OF AMBULATORY CARE SETTINGS
EXHIBIT 17 IMPACT OF EXPANSION OF PATIENT POPULATIONS & SHORTAGE OF HEALTHCARE WORKERS
EXHIBIT 18 IMPACT OF VITAL SIGN MONITORING DEVICES ON AGING POPULATION CARE AND SHORTAGE OF HEALTHCARE WORKERS
EXHIBIT 19 IMPACT OF CHALLENGES ASSOCIATED WITH REMOTELY MONITORING PATIENTS THROUGH VITAL SIGN MONITORS
EXHIBIT 20 IMPACT OF FALSE ALARMS RELATED TO VITAL SIGN MONITORING DEVICES
EXHIBIT 21 IMPACT OF CYBERSECURITY & RELATED LIMITATIONS OF VITAL SIGNS MONITORING DEVICES
EXHIBIT 22 IMPACT OF PERCEPTIONS OF INADEQUATE ACCURACY & RELIABILITY OF WIRELESS VITAL SIGNS MONITORING DEVICES
EXHIBIT 23 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: MARKET SHARE 2022 & 2028
EXHIBIT 24 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET: MARKET SHARE 2022 & 2028
EXHIBIT 25 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: MARKET SHARE 2022 & 2028
EXHIBIT 26 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: MARKET SHARE 2022 & 2028
EXHIBIT 27 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USERS: MARKET SHARE 2022 & 2028
EXHIBIT 28 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: MARKET SHARE 2022 & 2028
EXHIBIT 29 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 30 FIVE FORCES ANALYSIS 2022
EXHIBIT 31 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
EXHIBIT 32 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028
EXHIBIT 33 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: SEGMENTAL OVERVIEW
EXHIBIT 34 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: INCREMENTAL GROWTH
EXHIBIT 35 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT: ABSOLUTE GROWTH
EXHIBIT 36 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 38 APPLICATIONS OF HEART RATE MONITORS
EXHIBIT 39 GROWTH FACTORS & CHALLENGES FOR WEARABLE HEART RATE MONITORS
EXHIBIT 40 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY HEART RATE/ CARDIAC MONITORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY HEART RATE/ CARDIAC MONITORS 2022–2028 ($ BILLION)
EXHIBIT 42 APPLICATIONS OF PULSE OXIMETERS
EXHIBIT 43 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY PULSE OXIMETERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 44 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY PULSE OXIMETERS 2022–2028 ($ BILLION)
EXHIBIT 45 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BLOOD PRESSURE MONITORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BLOOD PRESSURE MONITORS 2022–2028 ($ BILLION)
EXHIBIT 47 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BODY TEMPERATURE MONITORS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY BODY TEMPERATURE MONITORS 2022–2028 ($ BILLION)
EXHIBIT 49 INTEGRATION OF VITAL SIGN MONITORING DEVICES AND THEIR IMPACT
EXHIBIT 50 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 51 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 52 INCREMENTAL GROWTH BY PATIENT GROUP 2022 & 2028
EXHIBIT 53 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028
EXHIBIT 54 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: SEGMENTAL OVERVIEW
EXHIBIT 55 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: INCREMENTAL GROWTH
EXHIBIT 56 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP: ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL PREVALENCE OF CHRONIC CONDITIONS AMONG GERIATRICS THAT REQUIRE VITAL SIGN MONITORING DEVICES
EXHIBIT 58 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 59 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP 2022–2028 ($ BILLION)
EXHIBIT 60 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP 2022–2028 ($ BILLION)
EXHIBIT 62 GLOBAL PREVALENCE OF CHRONIC DISEASES AMONG ADULTS 2021
EXHIBIT 63 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP 2022–2028 ($ BILLION)
EXHIBIT 65 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028
EXHIBIT 66 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028
EXHIBIT 67 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: SEGMENTAL OVERVIEW
EXHIBIT 68 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 69 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 70 BENEFITS OF REMOTE MONITORING & VITAL SIGN MONITORS FOR CHRONIC CARE MANAGEMENT
EXHIBIT 71 GLOBAL BURDEN OF MAJOR CHRONIC CONDITIONS
EXHIBIT 72 DISTRIBUTION OF REMOTE PATIENT MONITORING ACCORDING TO CHRONIC CONDITIONS 2021
EXHIBIT 73 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 74 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE 2022–2028 ($ BILLION)
EXHIBIT 75 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 76 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE 2022–2028 ($ BILLION)
EXHIBIT 77 INCREMENTAL GROWTH BY END USER 2022 & 2028
EXHIBIT 78 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028
EXHIBIT 79 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER: SEGMENTAL OVERVIEW
EXHIBIT 80 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USERS: INCREMENTAL GROWTH
EXHIBIT 81 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USERS: ABSOLUTE GROWTH
EXHIBIT 82 MAJOR VITAL SIGN MONITORING DEVICES REQUIRED IN HOSPITAL SETTINGS
EXHIBIT 83 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 84 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS 2022–2028 ($ BILLION)
EXHIBIT 85 ROLE OF VITAL SIGN MONITORS IN AMBULATORY CARE SETTINGS
EXHIBIT 86 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 87 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS 2022–2028 ($ BILLION)
EXHIBIT 88 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 89 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS 2022–2028 ($ BILLION)
EXHIBIT 90 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 91 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS 2022–2028 ($ BILLION)
EXHIBIT 92 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
EXHIBIT 93 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028
EXHIBIT 94 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: GEOGRAPHIC OVERVIEW
EXHIBIT 95 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 96 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 97 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 98 NORTH AMERICA MAJOR CHRONIC CONDITIONS & ASSOCIATED PATIENT POPULATION
EXHIBIT 99 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 100 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 101 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
EXHIBIT 102 GROWTH OF RPM INTEGRATION IN US
EXHIBIT 103 US VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 104 CANADA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 105 EUROPE VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 106 EUROPE VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 107 EUROPE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
EXHIBIT 109 PREFERENCE FOR CONTINUOUS GLUCOSE MONITORING DEVICES IN GERMANY 2022 (%)
EXHIBIT 110 GERMANY VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 111 FRANCE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 112 PREVALENCE OF MAJOR CHRONIC DISEASES IN UK 2023
EXHIBIT 113 UK VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 114 ITALY VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 115 SPAIN VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 116 APAC VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 117 APAC VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 118 APAC VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 119 INCREMENTAL GROWTH IN APAC 2022 & 2028
EXHIBIT 120 ABSOLUTE BURDEN OF HYPERTENSION AMONG ADULTS IN 18–69 AGE GROUP IN CHINA 2004–2018
EXHIBIT 121 CHINA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 122 TOP 10 DISEASES WITH HIGHEST MORTALITY RATE IN JAPAN 2020
EXHIBIT 123 JAPAN VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 124 CHRONIC & ACUTE DISEASES BURDEN IN INDIA
EXHIBIT 125 INDIA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 126 PREVALENCE OF CHRONIC DISEASES IN SOUTH KOREA IN 2022
EXHIBIT 127 SOUTH KOREA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 128 CHRONIC DISEASES PREVALENCE IN AUSTRALIA 2020
EXHIBIT 129 AUSTRALIA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 130 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 131 MAJOR CHRONIC DISEASES BURDEN IN LATIN AMERICA 2022
EXHIBIT 132 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 133 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 134 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
EXHIBIT 135 BRAZIL VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 136 MEXICO VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 137 ARGENTINA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 138 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 139 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET: KEY COUNTRIES
EXHIBIT 140 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 141 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
EXHIBIT 142 TURKEY VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 143 SAUDI ARABIA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 144 SOUTH AFRICA VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 145 UAE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
EXHIBIT 146 A&D COMPANY ANNUAL REVENUE 2018–2020 ($ MILLION)
EXHIBIT 147 GE COMPANY & GE HEALTHCARE ANNUAL REVENUE 2019–2022 ($)
EXHIBIT 148 BAXTER ANNUAL REVENUE 2019–2022 ($ MILLION)
EXHIBIT 149 ICU MEDICAL ANNUAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 150 ICU MEDICAL REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 151 KONINKLIJKE PHILIPS ANNUAL REVENUE 2020-2022 ($ BILLION)
EXHIBIT 152 KONINKLIJKE PHILIPS ANNUAL REVENUE BY BUSINESS SEGMENT 2022 (%)
EXHIBIT 153 MASIMO ANNUAL REVENUE 2019–2022 ($ MILLION)
EXHIBIT 154 MEDTRONIC ANNUAL REVENUE 2019-2021 ($ BILLION)
EXHIBIT 155 MEDTRONIC ANNUAL REVENUE SHARE BY BUSINESS SEGMENT 2022 (%)
EXHIBIT 156 MEDTRONIC ANNUAL REVENUE BY GEOGRAPHY 2022 (%)
EXHIBIT 157 NIHON KOHDEN ANNUAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 158 OSI SYSTEMS HEALTHCARE ANNUAL REVENUE 2020–2022 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2022
TABLE 3 EXAMPLES OF VITAL SIGN MONITORING DEVICES FOR AMBULATORY CARE SETTINGS
TABLE 4 MAJOR CHALLENGES IN REMOTELY MONITORING PATIENTS WITH VITAL SIGN MONITORING DEVICES
TABLE 5 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 6 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 7 GLOBAL PREVALENCE OF MAJOR CVD CONDITIONS 2022
TABLE 8 VENDORS ACTIVITIES IN BLOOD PRESSURE MONITORING SECTOR
TABLE 9 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 10 GLOBAL INTEGRATED VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 11 GLOBAL GERIATRIC VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP 2022–2028 ($ BILLION) (GEOGRAPHY)
TABLE 12 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GERIATRIC PATIENT GROUP 2022–2028 (%) (GEOGRAPHY)
TABLE 13 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 14 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PEDIATRIC PATIENT GROUP 2022–2028 (%)
TABLE 15 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 16 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ADULT PATIENT GROUP 2022–2028 (%)
TABLE 17 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE 2022–2028 ($ BILLION) (GEOGRAPHY)
TABLE 18 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY CHRONIC CARE 2022–2028 (%) (GEOGRAPHY)
TABLE 19 GLOBAL INFECTIOUS DISEASES REGISTERED CASES 2019–2022
TABLE 20 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE 2022–2028 ($ BILLION) (GEOGRAPHY)
TABLE 21 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY ACUTE CARE 2022–2028 (%) (GEOGRAPHY)
TABLE 22 NUMBER OF HOSPITALS ICU BEDS PER 100,000 AND TOTAL NUMBER OF HOSPITALS BY COUNTRY
TABLE 23 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS 2022–2028 ($ BILLION) (GEOGRAPHY)
TABLE 24 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOSPITALS 2022–2028 (%) (GEOGRAPHY)
TABLE 25 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS 2022–2028 ($ BILLION) (GEOGRAPHY)
TABLE 26 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OUTPATIENT CARE SETTINGS 2022–2028 (%) (GEOGRAPHY)
TABLE 27 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS 2022–2028 ($ BILLION) (GEOGRAPHY)
TABLE 28 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY HOMECARE SETTINGS & INDIVIDUALS 2022–2028 (%) (GEOGRAPHY)
TABLE 29 NUMBER OF MEDICAL ACADEMIC INSTITUTIONS BY COUNTRIES (2022)
TABLE 30 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS 2022−2028 ($ BILLION) (GEOGRAPHY)
TABLE 31 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY OTHER END USERS 2022−2028 (%) (GEOGRAPHY)
TABLE 32 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 33 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 34 NORTH AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
TABLE 35 NORTH AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)
TABLE 36 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 37 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 38 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 39 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 40 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 41 NORTH AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)
TABLE 42 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCTS 2022–2028 ($ BILLION)
TABLE 43 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 44 EUROPE STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
TABLE 45 EUROPE STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)
TABLE 46 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 47 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 48 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 49 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 50 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 51 EUROPE VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)
TABLE 52 ADVANCES IN REMOTE HEALTHCARE DURING & POST COVID-19 IN APAC
TABLE 53 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCTS 2022–2028 ($ BILLION)
TABLE 54 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 55 APAC STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
TABLE 56 APAC STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)
TABLE 57 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 58 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 59 APAC VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 60 APAC VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 61 APAC VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 62 APAC VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)
TABLE 63 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 64 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 65 LATIN AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
TABLE 66 LATIN AMERICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)
TABLE 67 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 68 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 69 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 70 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 71 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 72 LATIN AMERICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)
TABLE 73 MIDDLE EAST & AFRICAN COUNTRIES WITH INCLUSIVE DIGITAL HEALTH INITIATIVES 2022
TABLE 74 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCTS 2022–2028 ($ BILLION)
TABLE 75 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 76 MIDDLE EAST & AFRICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
TABLE 77 MIDDLE EAST & AFRICA STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)
TABLE 78 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 79 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 80 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 81 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 82 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 83 MIDDLE EAST & AFRICA VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)
TABLE 84 MERGER & ACQUISITIONS IN VITAL SIGNS MONITORING DEVICES MARKET IN RECENT YEARS
TABLE 85 PRODUCT LAUNCHES 2020–2021
TABLE 86 A&D COMPANY: MAJOR PRODUCT OFFERINGS
TABLE 87 CONTEC MEDICAL SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 88 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 89 BAXTER: MAJOR PRODUCT OFFERINGS
TABLE 90 ICU MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 91 KONINKLIJKE PHILIPS: MAJOR PRODUCT OFFERINGS
TABLE 92 MASIMO: MAJOR PRODUCT OFFERINGS
TABLE 93 MEDTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 94 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS
TABLE 95 NONIN: MAJOR PRODUCT OFFERINGS
TABLE 96 OMRON: MAJOR PRODUCT OFFERINGS
TABLE 97 OSI SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 98 100PLUS: MAJOR PRODUCT OFFERINGS
TABLE 99 ARJO (HUNTLEIGH HEALTHCARE LIMITED): MAJOR PRODUCT OFFERINGS
TABLE 100 AMERICAN DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
TABLE 101 ADVANCED INSTRUMENTATIONS: MAJOR PRODUCT OFFERINGS
TABLE 102 BIOFOURMIS: MAJOR PRODUCT OFFERINGS
TABLE 103 BITTIUM: MAJOR PRODUCT OFFERINGS
TABLE 104 BIOINTELLISENSE: MAJOR PRODUCT OFFERINGS
TABLE 105 CARDINAL HEALTH: MAJOR PRODUCT OFFERINGS
TABLE 106 COMPASS HEALTH BRANDS: MAJOR PRODUCT OFFERINGS
TABLE 107 DRÄGERWERK AG & CO.: MAJOR PRODUCT OFFERINGS
TABLE 108 ESSENCE: MAJOR PRODUCT OFFERINGS
TABLE 109 EDAN INSTRUMENTS: MAJOR PRODUCT OFFERINGS
TABLE 110 FUKUDA DENSHI: MAJOR PRODUCT OFFERINGS
TABLE 111 HALMA: MAJOR PRODUCT OFFERINGS
TABLE 112 INFINIUM MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 113 MENNEN MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 114 MICROLIFE: MAJOR PRODUCT OFFERINGS
TABLE 115 NURECA: MAJOR PRODUCT OFFERINGS
TABLE 116 OXITONE: MAJOR PRODUCT OFFERINGS
TABLE 117 QARDIO: MAJOR PRODUCT OFFERINGS
TABLE 118 ROSSMAX INTERNATIONAL: MAJOR PRODUCT OFFERINGS
TABLE 119 SOLARIS MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 120 SUNSET HEALTHCARE SOLUTIONS: MAJOR PRODUCT OFFERINGS
TABLE 121 TURTLE SHELL TECHNOLOGIES PVT. LTD.: MAJOR PRODUCT OFFERINGS
TABLE 122 VIATOM TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 123 VITALCONNECT: MAJOR PRODUCT OFFERINGS
TABLE 124 VIVALNK: MAJOR PRODUCT OFFERINGS
TABLE 125 VYAIRE MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 126 COSINUSS: MAJOR PRODUCT OFFERINGS
TABLE 127 BETTER LIFE MEDICAL TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 128 TAIDOC: MAJOR PRODUCT OFFERINGS
TABLE 129 AXCENT MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 130 GENERAL MEDITECH: MAJOR PRODUCT OFFERINGS
TABLE 131 CLARITY MEDICAL: MAJOR PRODUCT OFFERINGS
TABLE 132 HICKS THERMOMETERS INDIA: MAJOR PRODUCT OFFERINGS
TABLE 133 MEDICAL ECONET: MAJOR PRODUCT OFFERINGS
TABLE 134 MEDITECH: MAJOR PRODUCT OFFERINGS
TABLE 135 TABLE 72 SHENZHEN CREATIVE INDUSTRY: MAJOR PRODUCT OFFERINGS
TABLE 136 PROGETTI: MAJOR PRODUCT OFFERINGS
TABLE 137 GETEMED MEDICAL AND INFORMATION TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 138 SHENZHEN UNICARE ELECTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 139 OPTO CIRCUITS (INDIA): MAJOR PRODUCT OFFERINGS
TABLE 140 BEIJING CHOICE ELECTRONIC TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 141 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS: MAJOR PRODUCT OFFERINGS
TABLE 142 REMOTE DIAGNOSTIC TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 143 SAMTRONIC: MAJOR PRODUCT OFFERINGS
TABLE 144 CHARMCARE: MAJOR PRODUCT OFFERINGS
TABLE 145 AVI HEALTHCARE: MAJOR PRODUCT OFFERINGS
TABLE 146 RECORDERS & MEDICARE SYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 147 ACARE TECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 148 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 ($ BILLION)
TABLE 149 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY GEOGRAPHY 2022–2028 (%)
TABLE 150 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 ($ BILLION)
TABLE 151 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PRODUCT 2022–2028 (%)
TABLE 152 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 ($ BILLION)
TABLE 153 GLOBAL STANDALONE VITAL SIGNS MONITORING DEVICES MARKET 2022–2028 (%)
TABLE 154 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 ($ BILLION)
TABLE 155 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY PATIENT GROUP 2022–2028 (%)
TABLE 156 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 ($ BILLION)
TABLE 157 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY APPLICATION 2022–2028 (%)
TABLE 158 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 ($ BILLION)
TABLE 159 GLOBAL VITAL SIGNS MONITORING DEVICES MARKET BY END USER 2022–2028 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
